Centro Ricerca Tettamanti, Pediatric Dep, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
IRCCS, Humanitas Clinical and Research Center, Rozzano (Mi), Italy.
Br J Haematol. 2021 Jun;193(6):1157-1171. doi: 10.1111/bjh.17330. Epub 2021 Mar 13.
B-cell acute lymphoblastic leukaemia (B-ALL) reprograms the surrounding bone marrow (BM) stroma to create a leukaemia-supportive niche. To elucidate the contribution of immune cells to the leukaemic microenvironment, we investigated the involvement of monocyte/macrophage compartments, as well as several recruitment pathways in B-ALL development. Immunohistochemistry analyses showed that CD68-expressing macrophages were increased in leukaemic BM biopsies, compared to controls and predominantly expressed the M2-like markers CD163 and CD206. Furthermore, the "non-classical" CD14 CD16 monocyte subset, expressing high CX3CR1 levels, was significantly increased in B-ALL patients' peripheral blood. CX3CL1 was shown to be significantly upregulated in leukaemic BM plasma, thus providing an altered migratory pathway possibly guiding NC monocyte recruitment into the BM. Additionally, the monocyte/macrophage chemoattractant chemokine ligand 2 (CCL2) strongly increased in leukaemic BM plasma, possibly because of the interaction of leukaemic cells with mesenchymal stromal cells and vascular cells and due to a stimulatory effect of leukaemia-related inflammatory mediators. C5a, a macrophage chemoattractant and M2-polarizing factor, further appeared to be upregulated in the leukaemic BM, possibly as an effect of PTX3 decrease, that could unleash complement cascade activation. Overall, deregulated monocyte/macrophage compartments are part of the extensive BM microenvironment remodelling at B-ALL diagnosis and could represent valuable targets for novel treatments to be coupled with classical chemotherapy.
B 细胞急性淋巴细胞白血病 (B-ALL) 重新编程周围骨髓 (BM) 基质,以创建支持白血病的小生境。为了阐明免疫细胞对白血病微环境的贡献,我们研究了单核细胞/巨噬细胞区室以及几种募集途径在 B-ALL 发展中的参与。免疫组织化学分析显示,与对照相比,白血病 BM 活检中 CD68 表达的巨噬细胞增加,并且主要表达 M2 样标志物 CD163 和 CD206。此外,“非经典”CD14 CD16 单核细胞亚群在 B-ALL 患者的外周血中显著增加,表达高水平的 CX3CR1。显示 CX3CL1 在白血病 BM 血浆中明显上调,从而提供了一种改变的迁移途径,可能指导 NC 单核细胞募集到 BM。此外,单核细胞/巨噬细胞趋化因子配体 2 (CCL2) 在白血病 BM 血浆中强烈增加,可能是由于白血病细胞与间充质基质细胞和血管细胞相互作用,以及白血病相关炎症介质的刺激作用。C5a,一种巨噬细胞趋化因子和 M2 极化因子,似乎在白血病 BM 中进一步上调,可能是由于 PTX3 减少的影响,这可能引发补体级联激活。总体而言,失调的单核细胞/巨噬细胞区室是 B-ALL 诊断时广泛 BM 微环境重塑的一部分,并且可能是与经典化疗相结合的新型治疗的有价值的靶标。